Alpha Centric Advisors LLC Sutro Biopharma, Inc. Transaction History

Alpha Centric Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 25, 2022	SELL	$14.25 - $23.53 $370,500 - $611,780	-26,000 Closed	0 $0
Q3 2021 Mar 09, 2022	SELL	$16.88 - $22.38 $16,880 - $22,380	-1,000 Reduced 3.7%	26,000 $491,000
Q2 2021 Mar 09, 2022	BUY	$18.03 - $23.82 $414,690 - $547,860	23,000 Added 575.0%	27,000 $502,000
Q4 2020 Mar 11, 2022	BUY	$10.16 - $23.98 $40,640 - $95,920	4,000 New	4,000 $87,000

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $140M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.